吉兰 - 巴雷综合征是什么?
Sonja E Leonhard1, Nowshin Papri2,3, Luis Querol4,5
1Department of Clinical Microbiology and Infectious Disease, Erasmus MC, Rotterdam, The Netherlands.
Nature reviews. Disease primers
|December 20, 2024
概括
吉兰-巴雷综合征 (GBS) 是一种导致神经损伤和的免疫疾病. 虽然有治疗方法,但了解GBS的原因和改善患者的治疗结果仍然存在重大挑战.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 吉兰-巴雷综合征 (GBS) 是一种罕见的免疫媒介多基基隆神经病,其特征是快速,渐进的软弱和感官缺陷.
- 它通常是感染后发生的,与神经化物有关的分子模仿有关,如Campylobacter jejuni感染中所见.
- 尽管有像血交换和IVIg这样的有效治疗方法,但很大一部分患者会经历残留残疾或死亡.
研究的目的:
- 总结目前对吉-巴雷综合征 (GBS) 的理解,包括其发病,诊断和治疗.
- 突出关键的知识差距,特别是关于病毒感染后的病原体和诊断和预后生物标志物的需求.
- 概述未来的挑战,包括开发更有效,个性化和可访问的治疗方法,并为GBS爆发做好准备.
主要方法:
- 临床特征是主要的诊断基础.
- 脑脊液分析和神经传导研究提供了支持性诊断证据.
- 审查现有的文献和临床数据关于GBS的发病,诊断,治疗和结果.
主要成果:
- GBS是一种免疫介导的神经病变,通常由感染引发,导致外周神经受损.
- 诊断依赖于临床表现,脑脊液分析和神经传导研究.
- 目前的治疗方法 (PLEX,IVIg) 改善了结果,但约20%的患者在6个月后仍然无法行走,约5%的患者死亡.
结论:
- 关于GBS的发病因子,特别是病毒后触发因子,仍然存在重大知识差距.
- 迫切需要特定的生物标志物来改善诊断,疾病监测和结果预测.
- 未来的研究必须专注于开发负担得起,个性化的治疗方法和为GBS爆发做好流行病准备.
更多相关视频
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.4K
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.7K
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests
642
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
642
Disorders of the Skeletal Muscle
871
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
871
Chemical Synapses
8.7K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.7K
Cross-bridge Cycle
116.8K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.8K
